|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
Document/Exhibit Description Pages Size
1: S-4 Registration Statement - Securities for a Merger HTML 946K
9: EX-3.10 Articles of Incorporation/Organization or Bylaws HTML 95K
10: EX-3.11 Articles of Incorporation/Organization or Bylaws HTML 42K
11: EX-3.12 Articles of Incorporation/Organization or Bylaws HTML 51K
12: EX-3.13 Articles of Incorporation/Organization or Bylaws HTML 44K
13: EX-3.14 Articles of Incorporation/Organization or Bylaws HTML 81K
14: EX-3.15 Articles of Incorporation/Organization or Bylaws HTML 41K
15: EX-3.16 Articles of Incorporation/Organization or Bylaws HTML 52K
16: EX-3.17 Articles of Incorporation/Organization or Bylaws HTML 33K
17: EX-3.18 Articles of Incorporation/Organization or Bylaws HTML 60K
18: EX-3.19 Articles of Incorporation/Organization or Bylaws HTML 34K
19: EX-3.20 Articles of Incorporation/Organization or Bylaws HTML 61K
20: EX-3.21 Articles of Incorporation/Organization or Bylaws HTML 42K
21: EX-3.22 Articles of Incorporation/Organization or Bylaws HTML 51K
22: EX-3.23 Articles of Incorporation/Organization or Bylaws HTML 59K
23: EX-3.24 Articles of Incorporation/Organization or Bylaws HTML 51K
24: EX-3.25 Articles of Incorporation/Organization or Bylaws HTML 39K
25: EX-3.26 Articles of Incorporation/Organization or Bylaws HTML 51K
26: EX-3.27 Articles of Incorporation/Organization or Bylaws HTML 42K
27: EX-3.28 Articles of Incorporation/Organization or Bylaws HTML 55K
28: EX-3.29 Articles of Incorporation/Organization or Bylaws HTML 60K
2: EX-3.3 Articles of Incorporation/Organization or Bylaws HTML 60K
29: EX-3.30 Articles of Incorporation/Organization or Bylaws HTML 47K
30: EX-3.31 Articles of Incorporation/Organization or Bylaws HTML 62K
31: EX-3.32 Articles of Incorporation/Organization or Bylaws HTML 61K
32: EX-3.33 Articles of Incorporation/Organization or Bylaws HTML 75K
33: EX-3.34 Articles of Incorporation/Organization or Bylaws HTML 54K
34: EX-3.35 Articles of Incorporation/Organization or Bylaws HTML 41K
35: EX-3.36 Articles of Incorporation/Organization or Bylaws HTML 81K
36: EX-3.37 Articles of Incorporation/Organization or Bylaws HTML 47K
37: EX-3.38 Articles of Incorporation/Organization or Bylaws HTML 80K
38: EX-3.39 Articles of Incorporation/Organization or Bylaws HTML 45K
3: EX-3.4 Articles of Incorporation/Organization or Bylaws HTML 68K
39: EX-3.40 Articles of Incorporation/Organization or Bylaws HTML 48K
40: EX-3.41 Articles of Incorporation/Organization or Bylaws HTML 35K
41: EX-3.42 Articles of Incorporation/Organization or Bylaws HTML 83K
42: EX-3.43 Articles of Incorporation/Organization or Bylaws HTML 188K
43: EX-3.44 Articles of Incorporation/Organization or Bylaws HTML 83K
44: EX-3.45 Articles of Incorporation/Organization or Bylaws HTML 42K
45: EX-3.46 Articles of Incorporation/Organization or Bylaws HTML 150K
46: EX-3.47 Articles of Incorporation/Organization or Bylaws HTML 56K
47: EX-3.48 Articles of Incorporation/Organization or Bylaws HTML 58K
48: EX-3.49 Articles of Incorporation/Organization or Bylaws HTML 44K
4: EX-3.5 Articles of Incorporation/Organization or Bylaws HTML 33K
49: EX-3.50 Articles of Incorporation/Organization or Bylaws HTML 51K
50: EX-3.51 Articles of Incorporation/Organization or Bylaws HTML 62K
51: EX-3.52 Articles of Incorporation/Organization or Bylaws HTML 66K
52: EX-3.53 Articles of Incorporation/Organization or Bylaws HTML 31K
53: EX-3.54 Articles of Incorporation/Organization or Bylaws HTML 59K
54: EX-3.55 Articles of Incorporation/Organization or Bylaws HTML 43K
55: EX-3.56 Articles of Incorporation/Organization or Bylaws HTML 66K
56: EX-3.57 Articles of Incorporation/Organization or Bylaws HTML 35K
57: EX-3.58 Articles of Incorporation/Organization or Bylaws HTML 45K
58: EX-3.59 Articles of Incorporation/Organization or Bylaws HTML 65K
5: EX-3.6 Articles of Incorporation/Organization or Bylaws HTML 81K
59: EX-3.60 Articles of Incorporation/Organization or Bylaws HTML 54K
60: EX-3.61 Articles of Incorporation/Organization or Bylaws HTML 32K
61: EX-3.62 Articles of Incorporation/Organization or Bylaws HTML 49K
62: EX-3.63 Articles of Incorporation/Organization or Bylaws HTML 96K
63: EX-3.64 Articles of Incorporation/Organization or Bylaws HTML 77K
64: EX-3.65 Articles of Incorporation/Organization or Bylaws HTML 56K
65: EX-3.66 Articles of Incorporation/Organization or Bylaws HTML 93K
66: EX-3.67 Articles of Incorporation/Organization or Bylaws HTML 50K
67: EX-3.68 Articles of Incorporation/Organization or Bylaws HTML 48K
68: EX-3.69 Articles of Incorporation/Organization or Bylaws HTML 33K
6: EX-3.7 Articles of Incorporation/Organization or Bylaws HTML 30K
69: EX-3.70 Articles of Incorporation/Organization or Bylaws HTML 46K
70: EX-3.71 Articles of Incorporation/Organization or Bylaws HTML 35K
71: EX-3.72 Articles of Incorporation/Organization or Bylaws HTML 82K
7: EX-3.8 Articles of Incorporation/Organization or Bylaws HTML 41K
8: EX-3.9 Articles of Incorporation/Organization or Bylaws HTML 61K
72: EX-4.8 Instrument Defining the Rights of Security Holders HTML 732K
73: EX-4.9 Instrument Defining the Rights of Security Holders HTML 725K
74: EX-5.1 Opinion of Counsel re: Legality HTML 40K
75: EX-5.2 Opinion of Counsel re: Legality HTML 42K
76: EX-5.3 Opinion of Counsel re: Legality HTML 48K
77: EX-10.1 Material Contract HTML 121K
78: EX-10.2 Material Contract HTML 121K
79: EX-22.1 Published Report re: Matters Submitted to a Vote HTML 39K
of Security Holders
80: EX-23.1 Consent of Expert or Counsel HTML 30K
81: EX-25.1 Statement of Eligibility to Act as a Trustee HTML 104K
84: EX-FILING FEES Filing Fees HTML 48K
82: EX-99.1 Miscellaneous Exhibit HTML 78K
83: EX-99.2 Miscellaneous Exhibit HTML 47K
| EX-3.35 |
Exhibit 3.35
QUINTILES PHARMA, INC.
ARTICLES OF INCORPORATION
The undersigned, hereby submits these Articles of Incorporation for the purpose of forming a business corporation under and by virtue of the laws of the State of North Carolina:
1. The name of the corporation is Quintiles Pharma, Inc.
2. The corporation shall have authority to issue one thousand (1,000) shares, all of one class, designated as common stock, with $0.001 par value per share. “Par value” shall mean the dollar amount fixed as the nominal or face value, as opposed to the market value, of each share of common stock.
3. The street address and county of the initial registered office of the corporation in the State of North Carolina are 225 Hillsborough Street, Raleigh, Wake County, North Carolina 27603, and the name of its initial registered agent at such address CT Corporation System.
4. The street address and county of the principal office of the Corporation are 4709 Creekstone Drive, Suite 200, Durham, Durham County, North Carolina 27703.
5. The name and address of the incorporator are Catherine A. Loughlin, Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P., 2500 Wachovia Capitol Center, Raleigh, Wake County, North Carolina 27601.
6. A director of the corporation shall not be personally liable to the corporation or otherwise for monetary damages for breach of any duty as a director, except for liability with respect to (i) acts or omissions that the director at the time of such breach knew or believed were clearly in conflict with the best interests of the corporation; (ii) any liability under N.C.Gen.Stat. 55-8-33 for unlawful distribution; or (iii) any transaction from which the director derived an improper personal benefit. If the North Carolina Business Corporation Act is amended to authorize corporate action for further eliminating or limiting personal liability of directors, then the liability of a director of the corporation shall be eliminated or limited to the fullest extent permitted by the North Carolina Business Corporation Act, as so amended.
Any repeal or modification of the foregoing paragraph shall not adversely affect any right or protection of a director of the corporation existing at the time of such repeal or modification.
7. The provisions of Article 9 and Article 9A of the North Carolina Business Corporation Act, entitled “The North Carolina Shareholder Protection Act” and “The North Carolina Control Share Acquisition Act,” respectively, shall not be applicable to the corporation.
8. The Corporation may conduct any transaction or transactions by electronic means, and this provision should constitute the agreements by the corporation, its shareholders and directors to the conduct of transactions by electronic means.
IN WITNESS WHEREOF, I have hereunto set my hand and affixed my official seal at the City of Raleigh, this 14th day of December, 2005.
| Catherine A. Loughlin, Incorporator |
ARTICLES OF MERGER
OF
QUINTILES AUSTRIAN HOLDINGS, LLC
INTO
QUINTILES PHARMA, INC.
Pursuant to North Carolina General Statute Section 55-11-05 (a), Quintiles Pharma, Inc., a North Carolina corporation (the “Surviving Corporation”), hereby submits these Articles of Merger as the surviving business entity for the purpose of merging Quintiles Austrian Holdings, LLC, a North Carolina limited liability company, with and into the Surviving Corporation:
1. The name of the Surviving Corporation is Quintiles Pharma, Inc., a North Carolina corporation.
2. The registered office street address of the Surviving Corporation is 150 Fayetteville St., Box 1011, Raleigh, NC 27601, Wake County.
3. The principal office address of the Surviving Corporation is 4820 Emperor Boulevard, Durham, NC 27703, Durham County.
4. The name of the merged entity is Quintiles Austrian Holdings, LLC, a North Carolina limited liability company.
5. A Plan of Merger has been duly approved in the manner prescribed by Chapter 55 of the General Statutes of North Carolina by the board of directors and shareholder of the Surviving Corporation and in the manner prescribed by Chapter 57C of the General Statutes of North Carolina by the sole member and manager of Quintiles Austrian Holdings, LLC.
6. These Articles of Merger will be effective upon filing.
This the 27th day of July, 2012.
| QUINTILES PHARMA, INC. | ||
| By: | /s/ Beverly Rubin | |
| Name: Beverly Rubin | ||
| Title: Vice President and Secretary | ||
QUINTILES PHARMA, INC.
ARTICLES OF AMENDMENT
Pursuant to Section 55-10-06 of the North Carolina Business Corporation Act, the undersigned corporation, Quintiles Pharma, Inc. (the “Corporation”), hereby submits these Articles of Amendment for the purpose of amending its Articles of Incorporation:
1. The name of the corporation is Quintiles Pharma, Inc.
2. Article 1 of the Articles of Incorporation of the Corporation is hereby amended to read as follows:
“1. The name of the corporation is IQVIA Pharma Inc.”
3. The foregoing amendment was proposed and recommended by the sole Director of the Corporation and approved and adopted by the sole shareholder of the Corporation in accordance with the provisions of Chapter 55 of the North Carolina General Statutes and the Corporation’s Articles of Incorporation. The date of adoption was November 6, 2017.
4. These articles will become effective upon filing.
IN WITNESS WHEREOF, I have hereunto set my hand this 6th day of November, 2017.
| QUINTILES PHARMA, INC. | ||
| By: | ||
| Name: James H. Erlinger | ||
| Title: Secretary | ||
ARTICLES OF AMENDMENT
OF
ARTICLES OF INCORPORATION
OF
IQVIA PHARMA INC.
Pursuant to Section 55-10-06 of the North Carolina Business Corporation Act, the undersigned corporation hereby submits these Articles of Amendment for the purpose of amending its Articles of Incorporation:
| 1. | The name of the corporation is IQVIA Pharma Inc. |
| 2. | The Articles of Incorporation of the corporation are hereby amended as follows: |
Section 2 shall be deleted in its entirety and substituted with the following:
“The corporation shall have authority to issue two thousand (2,000) shares, all of one class, designated as common stock, with $0.001 par value per share. “Par value” shall mean the dollar amount fixed as the nominal or face value, as opposed to the market value, of each share of common stock.”
| 2.1. | The foregoing amendment was approved and adopted as of November 19, 2019 by the corporation’s board of directors and as of November 19, 2019 by the corporation’s shareholders in the manner prescribed by Chapter 55 of the North Carolina General Statutes. |
| 3. | These Articles of Amendment will become effective upon filing. |
[Signature page follows.]
[Signature Page to Articles of Amendment of Articles of Incorporation of
IQVIA Pharma Inc.]
IN WITNESS WHEREOF, I have hereunto set my hand this 19th day of November, 2019.
| IQVIA PHARMA INC. | ||
| By: | /s/ Eric Sherbet | |
| Name: Eric Sherbet | ||
| Title: President | ||
| This ‘S-4’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/5/24 | |||
| 11/19/19 | ||||
| 11/6/17 | 4, 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/15/24 IQVIA Holdings Inc. 10-K 12/31/23 163:19M 1/18/24 IQVIA Holdings Inc. S-4/A 4:1.1M Donnelley … Solutions/FA 1/16/24 SEC UPLOAD¶ 2/21/24 2:56K Outcome Sciences, LLC |